Kenneth W Mahaffey Selected Research

Renal Dialysis (Hemodialysis)

3/2024	A Phase II randomized controlled trial evaluated antithrombotic treatment with fesomersen in patients with kidney failure on hemodialysis.
1/2023	Defining myocardial infarction in trials of people receiving hemodialysis: consensus report from the SONG-HD MI Expert Working group.
12/2022	Apixaban for Patients With Atrial Fibrillation on Hemodialysis: A Multicenter Randomized Controlled Trial.
7/2020	A double-blind, randomized, placebo-controlled pilot trial to evaluate safety and efficacy of vorapaxar on arteriovenous fistula maturation.
3/2016	Lessons Learned from EVOLVE for Planning of Future Randomized Trials in Patients on Dialysis.
7/2015	Cinacalcet, Fibroblast Growth Factor-23, and Cardiovascular Disease in Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial.
6/2015	Effects of Cinacalcet on Fracture Events in Patients Receiving Hemodialysis: The EVOLVE Trial.
5/2015	The Effects of Cinacalcet in Older and Younger Patients on Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial.
5/2015	Assessing the treatment effect in a randomized controlled trial with extensive non-adherence: the EVOLVE trial.
11/2014	Effects of cinacalcet on atherosclerotic and nonatherosclerotic cardiovascular events in patients receiving hemodialysis: the EValuation Of Cinacalcet HCl Therapy to Lower CardioVascular Events (EVOLVE) trial.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kenneth W Mahaffey Research Topics

Disease

157	Myocardial Infarction 04/2024 - 07/2001
151	Hemorrhage 03/2024 - 12/2002
138	Stroke (Strokes) 04/2024 - 12/2002
111	Acute Coronary Syndrome 11/2022 - 07/2001
107	Atrial Fibrillation 11/2023 - 06/2006
74	Type 2 Diabetes Mellitus (MODY) 04/2024 - 05/2010
66	Heart Failure 04/2024 - 06/2002
52	Embolism (Embolus) 03/2024 - 06/2008
43	Ischemia 03/2024 - 01/2002
43	Thrombosis (Thrombus) 03/2024 - 06/2008
32	Chronic Renal Insufficiency 04/2024 - 07/2008
32	Cardiovascular Diseases (Cardiovascular Disease) 01/2024 - 11/2005
31	Peripheral Arterial Disease 01/2023 - 07/2012
29	ST Elevation Myocardial Infarction 01/2022 - 09/2003
20	Albuminuria 01/2024 - 08/2016
17	Infarction (Infarctions) 09/2013 - 01/2002
16	Body Weight (Weight, Body) 01/2023 - 03/2010
15	Diabetic Nephropathies (Diabetic Nephropathy) 01/2024 - 01/2019
14	Ischemic Stroke 03/2024 - 09/2011
14	Renal Insufficiency (Renal Failure) 03/2024 - 09/2010
14	Kidney Diseases (Kidney Disease) 02/2024 - 07/2015
13	Coronary Artery Disease (Coronary Atherosclerosis) 04/2024 - 07/2006
13	Diabetes Mellitus 01/2022 - 06/2002
12	Infections 01/2022 - 09/2003
12	Transient Ischemic Attack 01/2022 - 02/2010
11	Intracranial Hemorrhages (Intracranial Hemorrhage) 11/2023 - 02/2004
11	Unstable Angina 01/2022 - 07/2001
10	Chronic Kidney Failure (Chronic Renal Failure) 02/2024 - 12/2017
10	Secondary Hyperparathyroidism 03/2016 - 09/2007
9	Hypertension (High Blood Pressure) 01/2021 - 02/2010
7	Coronary Disease (Coronary Heart Disease) 01/2023 - 06/2006
6	Hemorrhagic Stroke 01/2019 - 10/2012
5	Inflammation (Inflammations) 12/2021 - 10/2005
5	Heart Diseases (Heart Disease) 12/2021 - 04/2006
5	Stable Angina 11/2018 - 05/2012
5	Sudden Death 01/2016 - 10/2012
5	Shock 10/2013 - 09/2003
4	Vascular Diseases (Vascular Disease) 11/2022 - 06/2006
4	Cardiac Arrhythmias (Arrythmia) 10/2022 - 03/2012

Drug/Important Bio-Agent (IBA)

76	CanagliflozinIBA 01/2024 - 08/2013
66	Warfarin (Coumadin)FDA LinkGeneric 12/2022 - 02/2010
63	Clopidogrel (Plavix)FDA Link 11/2022 - 05/2008
56	RivaroxabanIBA 01/2022 - 06/2008
41	Vitamin K FDA Link 01/2022 - 01/2013
39	TicagrelorIBA 11/2022 - 09/2009
34	CreatinineIBA 02/2024 - 06/2002
34	cangrelorIBA 03/2022 - 12/2009
34	Factor Xa (Coagulation Factor Xa)IBA 01/2022 - 02/2012
31	AnticoagulantsIBA 11/2023 - 11/2003
26	Enoxaparin (Lovenox)FDA LinkGeneric 12/2021 - 01/2003
25	Glucose (Dextrose)FDA LinkGeneric 04/2024 - 07/2004
25	Biomarkers (Surrogate Marker)IBA 01/2023 - 08/2005
24	vorapaxarIBA 11/2022 - 03/2009
21	SodiumIBA 04/2024 - 08/2013
21	Thrombin Receptors (Thrombin Receptor)IBA 11/2022 - 01/2012
21	Heparin (Liquaemin)FDA LinkGeneric 03/2019 - 12/2002
20	Sodium-Glucose Transporter 2 InhibitorsIBA 04/2024 - 09/2015
20	Glycoproteins (Glycoprotein)IBA 01/2020 - 04/2002
17	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 09/2017 - 09/2004
16	omega-Chloroacetophenone (Mace)IBA 04/2024 - 12/2013
15	Sodium-Glucose Transport ProteinsIBA 01/2024 - 03/2015
14	AlbuminsIBA 11/2023 - 12/2017
14	pexelizumabIBA 11/2013 - 09/2003
13	SymportersIBA 04/2024 - 08/2013
12	Complement System Proteins (Complement)IBA 04/2024 - 09/2003
11	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 06/2006
11	Cinacalcet (Sensipar)FDA Link 03/2016 - 09/2007
10	MB Form Creatine KinaseIBA 10/2014 - 09/2003
9	Factor Xa InhibitorsIBA 01/2020 - 07/2010
9	Streptokinase FDA Link 09/2019 - 02/2004
9	Creatine Kinase (Creatine Phosphokinase)IBA 10/2014 - 08/2005
8	AntithrombinsIBA 09/2010 - 12/2003
7	TroponinIBA 01/2023 - 05/2007
6	pro-brain natriuretic peptide (1-76)IBA 04/2024 - 04/2006
6	apixabanIBA 12/2022 - 07/2010
6	N(4)-oleylcytosine arabinosideIBA 01/2021 - 12/2016
6	alirocumabIBA 12/2020 - 11/2014
6	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2018 - 08/2005
5	Brain Natriuretic Peptide (Natrecor)FDA Link 04/2024 - 04/2006
5	Glucagon-Like Peptide-1 Receptor AgonistsIBA 11/2023 - 11/2020
5	Hemoglobins (Hemoglobin)IBA 01/2022 - 03/2008
5	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 12/2021 - 12/2003
5	Peptide Hydrolases (Proteases)FDA Link 07/2020 - 03/2014
5	Anti-Arrhythmia AgentsIBA 01/2020 - 07/2013
5	Platelet Membrane Glycoprotein IIbIBA 05/2015 - 12/2002
5	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 03/2010 - 12/2002
4	Mineralocorticoid Receptor AntagonistsIBA 11/2023 - 01/2018
4	Growth Differentiation Factor 15IBA 11/2022 - 01/2014
4	DiureticsIBA 10/2022 - 01/2021
4	Insulin (Novolin)FDA Link 01/2022 - 03/2015

Therapy/Procedure

124	Therapeutics 04/2024 - 07/2001
57	Percutaneous Coronary Intervention 01/2023 - 09/2003
41	Stents 03/2024 - 12/2003
25	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2023 - 09/2004
16	Surgical Amputation (Amputations) 03/2024 - 09/2007
14	Renal Dialysis (Hemodialysis) 03/2024 - 09/2007
10	Patient Readmission 03/2017 - 11/2005
9	Secondary Prevention 01/2022 - 06/2008
8	Blood Transfusion (Blood Transfusions) 01/2018 - 07/2004
6	Thrombolytic Therapy 11/2017 - 12/2003